Senior insider sale
SVP and Pres, Lilly Bio-Meds at ELI LILLY & CO — senior position signals high conviction
$2.88M
2.50K shares
What this filing means
YUFFA ILYA plans to sell 2.50K shares of ELI LILLY & CO valued at approximately $2.88M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/10/2026ACC: 0001949846-26-000366
Officer· SVP and Pres, Lilly Bio-Meds
Since Oct 2020
2.50K
Shares to sell
$2.88M
Approx. market value
2.50K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
AWARD SHARES
NA
2/10/2025
2.50KTotal acquired2.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/10/2025 | AWARD SHARES NA | 2.50K | — |
| Total | 2.50K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
2.50K
Market value
$2.88M
6/10/2026
Total
Units
2.50K
Value
$2.88M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/10/2026 | 2.50K | $2.88M | NYSE | Planned |
| Total | 2.50K | $2.88M | ||